Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Axovant Sciences Ltd. | 99,285,714 | reported | 18 Dec 2018 | tx 1+10,000,000 |
| Myovant Sciences Ltd. | 40,765,599 | reported | 04 Jun 2019 | tx 1+2,424,242 |
| Urovant Sciences Ltd. | 22,798,460 | reported | 06 Jun 2019 | tx 7+42,730 |
| BridgeBio Pharma, Inc. | 22,055,375 | reported | 31 Jan 2025 | tx 1−3,065,616 |
| 4D Molecular Therapeutics, Inc. | 4,247,914 | reported | 04 Jan 2024 | tx 1−540,000 |
| Rallybio Corp | 4,194,777 | reported | 29 Jul 2021 | tx 3+4,194,777−21,578,387 |
| APi Group Corp | 1,912,750 | reported | 05 Mar 2024 | tx 2−3,038,617 |
| Inhibrx, Inc. | 1,327,307 | reported | 26 Aug 2020 | tx 2+180,219 |
| Amylyx Pharmaceuticals, Inc. | 0 | reported | 11 Nov 2022 | tx 19+7,170,536−6,270,536 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 31 Jan 2025 | SALE | BridgeBio Pharma, Inc. | 3,065,616 | 34.90 USD | |
| 05 Mar 2024 | SALE | APi Group Corp | 60,772 | 34.25 USD | |
| 05 Mar 2024 | SALE | APi Group Corp | 2,977,845 | 34.25 USD | |
| 04 Jan 2024 | SALE | 4D Molecular Therapeutics, Inc. | 540,000 | 19.53 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 15,996 | 30.59 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 111,102 | 32.23 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 38,116 | 27.28 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 51,298 | 28.16 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 75,096 | 29.14 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 7,554 | 30.59 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 52,466 | 32.23 USD | |
| 09 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 312,353 | 29.87 USD | |
| 09 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 156,463 | 30.90 USD | |
| 09 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 6,654 | 31.44 USD | |
| 09 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 147,502 | 29.87 USD | |
| 09 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 73,886 | 30.90 USD | |
| 09 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 3,142 | 31.44 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 159,026 | 29.14 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 80,715 | 27.28 USD | |
| 08 Sept 2022 | SALE | Amylyx Pharmaceuticals, Inc. | 108,631 | 28.16 USD | |
| 11 Jan 2022 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 2,300,000 | 19.00 USD | |
| 11 Jan 2022 | CONVERSION | Amylyx Pharmaceuticals, Inc. | 4,870,536 | — | |
| 11 Nov 2022 | CONVERSION | Amylyx Pharmaceuticals, Inc. | 4,870,536 | 0.00 USD | deriv |
| 29 Jul 2021 | CONVERSION | Rallybio Corp | 3,388,777 | — | |
| 29 Jul 2021 | PURCHASE | Rallybio Corp | 806,000 | 13.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 26 Aug 2020.